IL-10 Blocks Resistance to Schistosoma mansoni Re-Infection
Author Information
Author(s): Wilson Mark S., Cheever Allen W., White Sandra D., Thompson Robert W., Wynn Thomas A.
Primary Institution: National Institutes of Allergy and Infectious Disease, National Institutes of Health
Hypothesis
IL-10 is obstructing the development of resistance to re-infection with Schistosoma mansoni.
Conclusion
Blocking IL-10 signaling during treatment can enhance protective immunity against re-infection with Schistosoma mansoni.
Supporting Evidence
- Blocking IL-10 during treatment led to over 50% reduction in parasite establishment.
- Significant increases in anti-worm immune responses were observed post-treatment.
- IL-10-producing cells were significantly elevated in treated mice.
Takeaway
This study found that a substance called IL-10 stops the body from building up defenses against a parasite that causes schistosomiasis, and blocking it can help the body fight off the parasite better.
Methodology
Mice were treated with Praziquantel and anti-IL-10R antibodies to assess immune responses and resistance to re-infection.
Limitations
The study's findings may not fully translate to human infections due to differences in immune responses.
Participant Demographics
C57BL/6 female mice aged 6-8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website